Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins
- 11 March 2009
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (7) , 1113-1120
Abstract
Huntington disease (HD) mutation increases gain-of-toxic functions contributing to glutamate-mediated excitotoxicity. Riluzole interferes with glutamatergic neurotransmission, thereby reducing excitotoxicity, enhancing neurite formation in damaged motoneurons and increasing serum concentrations of BDNF, a brain cortex neurotrophin protecting striatal neurons from degeneration.Keywords
This publication has 33 references indexed in Scilit:
- Distinct Brain Volume Changes Correlating with Clinical Stage, Disease Progression Rate, Mutation Size, and Age at Onset Prediction as Early Biomarkers of Brain Atrophy in Huntington's DiseaseCNS Neuroscience & Therapeutics, 2009
- Molecular medicine: predicting and preventing Huntington’s diseaseNeurological Sciences, 2008
- Temporal cortex dopamine D2/3 receptor binding in major depressionPsychiatry and Clinical Neurosciences, 2008
- Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneityBrain, 2008
- Neural bases of dysphoria in early Huntington's diseasePsychiatry Research: Neuroimaging, 2008
- Low brain‐derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patientsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007
- Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathologyJournal of Clinical Investigation, 2006
- The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset predictionEuropean Journal of Neurology, 2006
- Co-treatment with riluzole and GDNF is necessary for functional recovery after ventral root avulsion injuryExperimental Neurology, 2004
- Riluzole enhances expression of brain‐derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampusThe FASEB Journal, 2002